Blog

Teva Pharmaceutical offers to buy Mylan for $40.1 bn

Israel’s Teva Pharmaceutical Tuesday launched an unsolicited bid to buy Mylan for $40.1 billion in a transaction that would create a behemoth in generic drugs. Teva’s cash-and-stock bid would quash an unsolicited bid by Mylan earlier this month to acquire Perrigo for $28.9 billion. Teva said its bid amounted to superior value for Mylan shareholders compared with Mylan’s approach to Perrigo. Under the offer, Mylan shareholders would receive a premium

Teva Pharmaceutical offers to buy Mylan for $40.1 bn

Israel’s Teva Pharmaceutical Tuesday launched an unsolicited bid to buy Mylan for $40.1 billion in a transaction that would create a behemoth in generic drugs. Teva’s cash-and-stock bid would quash an unsolicited bid by Mylan earlier this month to acquire Perrigo for $28.9 billion. Teva said its bid amounted to superior value for Mylan shareholders compared with Mylan’s approach to Perrigo. Under the offer, Mylan shareholders would receive a premium

Another study finds no link between vaccine, autism

Yet another scientific study has found no link between autism and the vaccine against measles, mumps and rubella (MMR), according to US research published on Tuesday. The findings in the Journal of the American Medical Association (JAMA) are based on a study of about 95,000 children with older siblings, some of whom had autism spectrum disorder (ASD). “Consistent with studies in other populations, we observed no association between MMR vaccination

Another study finds no link between vaccine, autism

Yet another scientific study has found no link between autism and the vaccine against measles, mumps and rubella (MMR), according to US research published on Tuesday. The findings in the Journal of the American Medical Association (JAMA) are based on a study of about 95,000 children with older siblings, some of whom had autism spectrum disorder (ASD). “Consistent with studies in other populations, we observed no association between MMR vaccination

New U.S. mammogram guidelines stick with screening from age 50

By Julie Steenhuysen CHICAGO (Reuters) – New mammogram screening guidelines from an influential panel of U.S. experts reaffirm earlier guidance that breast cancer screening should begin at age 50 for most women, but they acknowledge that women in their 40s also benefit, something experts say is a step in the right direction. “They made it really clear this time around, unlike 2009, that the discussion between a woman and a clinician

New U.S. mammogram guidelines stick with screening from age 50

By Julie Steenhuysen CHICAGO (Reuters) – New mammogram screening guidelines from an influential panel of U.S. experts reaffirm earlier guidance that breast cancer screening should begin at age 50 for most women, but they acknowledge that women in their 40s also benefit, something experts say is a step in the right direction. “They made it really clear this time around, unlike 2009, that the discussion between a woman and a clinician

Texas ice cream maker recalls all products over Listeria

By Marice Richter DALLAS (Reuters) – Texas-based Blue Bell Creameries announced on Monday a voluntary recall of all its ice cream and frozen treat products from store shelves due to continuing problems with the Listeria bacteria. The move is the most recent in a string of recall announcements by the 108-year-old company, based in Brenham, after health officials said last month three people made ill by Listeria between January 2014

Texas ice cream maker recalls all products over Listeria

By Marice Richter DALLAS (Reuters) – Texas-based Blue Bell Creameries announced on Monday a voluntary recall of all its ice cream and frozen treat products from store shelves due to continuing problems with the Listeria bacteria. The move is the most recent in a string of recall announcements by the 108-year-old company, based in Brenham, after health officials said last month three people made ill by Listeria between January 2014

Hormel Foods shares fall amid bird flu worries

CHICAGO (Reuters) – Hormel Foods Corp shares fell more than 3 percent Tuesday morning after the Minnesota-based company announced that the impact of a virulent strain of avian influenza may drag its fiscal 2015 earnings toward the lower end of guidance. The virus has been identified at a facility west of Minneapolis that is owned by a subsidiary of Hormel. Worries about the spread of the highly contagious virus also